Periodic screening pelvic examination evidence report and systematic review for the US Preventive Services Task Force

JAMA - Journal of the American Medical Association

Volumn 317, Issue 9, 2017, Pages 954-966

  Guirguis Blake, Janelle M ^a,b   Henderson, Jillian T ^b   Perdue, Leslie A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE GENITAL TRACT CANCER; GENITAL HERPES; HERPES SIMPLEX; HUMAN; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT HARM; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PREVENTIVE HEALTH SERVICE; QUALITY OF LIFE; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRICHOMONIASIS; VAGINITIS; ADULT; ADVERSE EFFECTS; CLINICAL TRIAL (TOPIC); FEMALE; GENITAL DISEASES, FEMALE; GYNECOLOGICAL EXAMINATION; MASS SCREENING; PROCEDURES;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; GENITAL DISEASES, FEMALE; GYNECOLOGICAL EXAMINATION; HUMANS; MASS SCREENING;

EID: 85015941127     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.12819     Document Type: Review

References (57)

1. National Center for Health Statistics. National Ambulatory Medical Care Survey: 2012 summary tables. Centers for Disease Control and Prevention website. http://www.cdc.gov/nchs/data/ahcd/namcs-summary/2012-namcs-web-tables.pdf. Accessed July 28, 2016.
2. Miller JW, Baldwin LM, Matthews B, et al. Physicians' beliefs about effectiveness of cancer screening tests: A national survey of family physicians, general internists, and obstetrician-gynecologists. Prev Med. 2014; 69:37-42.
3. Herman CR, Gill HK, Eng J, Fajardo LL. Screening for preclinical disease: Test and disease characteristics. AJR AmJ Roentgenol. 2002; 179(4):825-831.
4. Herman C. What makes a screening exam "good"?. Virtual Mentor. 2006;8(1):34-37.
5. LeFevre ML; U.S. Preventive Services Task Force. Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(12):902-910.
6. Moyer VA; U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement [published correction appears in Ann Intern Med. 2013;158(11):852.]. Ann Intern Med. 2012;156(12): 880-891.
7. ACOG Committee on Practice Bulletins- Gynecology. ACOG Practice Bulletin No. 109: Cervical cytology screening. Obstet Gynecol. 2009; 114(6):1409-1420.
8. Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol. 2012;120(5):1222-1238.
9. Westhoff CL, Jones HE, Guiahi M. Do new guidelines and technology make the routine pelvic examination obsolete?. JWomens Health (Larchmt). 2011;20(1):5-10.
10. Sawaya GF. Pelvic examinations in asymptomatic women: Tipping a sacred cow. Arch Intern Med. 2011;171(22):2054-2055.
11. Sawaya GF, Jacoby V. Screening pelvic examinations: Right, wrong, or rite?. Ann Intern Med. 2014;161(1):78-79.
12. Burns RB, Potter JE, Ricciotti HA, Reynolds EE. Screening pelvic examinations in adult women: Grand rounds discussion from the Beth Israel Deaconess Medical Center. Ann Intern Med. 2015; 163(7):537-547.
13. American College of Obstetricians and Gynecologists (ACOG). Committee Opinion: well-woman visit. ACOG website. http://www.acog .org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Well-Woman-Visit. 2012. Accessed August 21, 2014.
14. Qaseem A, Humphrey LL, Harris R, Starkey M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Screening pelvic examination in adult women: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(1):67-72.
15. American College of Obstetricians and Gynecologists (ACOG). ACOG practice advisory on annual pelvic examination recommendations. ACOG website. http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/ACOG-Practice-Advisory-on-Annual-Pelvic-Examination-Recommendations. 2014. Accessed November 5, 2015.
16. Harris RP, Helfand M,Woolf SH, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med. 2001;20(3)(suppl):21-35.
17. Bloomfield HE, Olson A, Greer N, et al. Screening pelvic examinations in asymptomatic, average-risk adult women: An evidence report for a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(1): 46-53.
18. Ebell MH, Culp M, Lastinger K, Dasigi T. A systematic review of the bimanual examination as a test for ovarian cancer. Am J Prev Med. 2015;48 (3):350-356.
19. Doroudi M, Kramer BS, Pinsky PF. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Performance and complications [published online November 30, 2016]. J Med Screen. doi:10.1177/0969141316680381
20. Wallace BC, Small K, Brodley CE, Lau J, Trikalinos TA. Deploying an interactive machine learning system in an Evidence-based Practice Center. Proceedings of the 2nd ACMSIGHIT International Health Informatics Symposium; January 28-30, 2012; Miami, FL. doi:10.1145/2110363.2110464.
21. United Nations Development Programme (UNDP). 2014 Human Development Report. UNDP website. http://www.undp.org/content/undp/en/home/presscenter/events/2014/july/HDR2014 .html. 2014. Accessed April 13, 2016.
22. Wells GA, O'Connell D, Peterson J,Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies inmeta-analysis. The Ottawa Hospital website. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. 2014. Accessed November 9, 2015.
23. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med ResMethodol. 2003;3:25.
24. Whiting PF, Rutjes AW,Westwood ME, et al; QUADAS-2 Group. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536.
25. Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1(8580):268-271.
26. Adonakis GL, Paraskevaidis E, Tsiga S, Seferiadis K, Lolis DE. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 1996;65 (2):221-225.
27. Grover S, Quinn MA,Weideman P, et al. Screening for ovarian cancer using serum CA125 and vaginal examination: Report on 2550 females. Int J Gynecol Cancer. 1995;5(4):291-295.
28. Prorok PC, Andriole GL, Bresalier RS, et al; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21 (6)(suppl):273S-309S.
29. Buys SS, Partridge E, Greene MH, et al; PLCO Project Team. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screen of a randomized trial [published correction appears in Am J Obstet Gynecol. 2005;193(6):2183-2184]. Am J Obstet Gynecol. 2005;193(5):1630-1639.
30. Gutman RE, Peipert JF,Weitzen S, Blume J. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol. 2005;105(3): 551-556.
31. Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988;158(4):819-828.
32. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992; 326(23):1533-1539.
33. Wølner-Hanssen P, Krieger JN, Stevens CE, et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261(4):571-576.
34. Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gramstain of vaginal fluid. J Clin Microbiol. 1983;18(1):170-177.
35. Tiemstra JD, Pela E. Urinary symptoms after a routine pelvic exam. J AmBoard Fam Med. 2011;24 (3):290-295.
36. Stormo AR, Cooper CP, Hawkins NA, SaraiyaM. Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women. Prev Med. 2012;54(6):415-421.
37. Henderson JT, Harper CC, Gutin S, SaraiyaM, Chapman J, Sawaya GF. Routine bimanual pelvic examinations: Practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol. 2013;208(2):109.e1-109.e7.
38. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute; 2015.
39. Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet. 2005;88(1):84-88.
40. Padilla LA, Radosevich DM, Milad MP. Accuracy of the pelvic examination in detecting adnexal masses. Obstet Gynecol. 2000;96(4):593-598.
41. Tayal VS, Crean CA, Norton HJ, Schulz CJ, Bacalis KN, Bliss S. Prospective comparative trial of endovaginal sonographic bimanual examination versus traditional digital bimanual examination in nonpregnant women with lower abdominal pain with regard to body mass index classification. J Ultrasound Med. 2008;27(8):1171-1177.
42. Ueland FR, Depriest PD, Desimone CP, et al. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol. 2005;99(2):400-403.
43. SaraiyaM. Evidence is lacking to support pelvic examinations as a screening tool for non-cervical cancers or other conditions. Evid Based Med. 2015; 20(1):31.
44. Bump RC. "Pelvic: Deferred"-have nongynecologists been right all along?. Am J Obstet Gynecol. 2013;208(2):91.
45. Bates C, Potter J. Screening pelvic examination in adult women. Ann Intern Med. 2014;161(12):925-926.
46. Metz S, Gussman D. Screening pelvic examination in adult women. Ann Intern Med. 2014; 161(12):925.
47. Jennings JC, Blake J. Screening pelvic examinations in asymptomatic, average-risk adult women. Ann Intern Med. 2014;161(12):924.
48. Harper C, Balistreri E, Boggess J, Leon K, Darney P. Provision of hormonal contraceptives without a mandatory pelvic examination: The First Stop demonstration project. Fam Plann Perspect. 2001;33(1):13-18.
49. Swahnberg K, Wijma B, Siwe K. Strong discomfort during vaginal examination: why consider a history of abuse?. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):200-205.
50. Weitlauf JC, Finney JW, Ruzek JI, et al. Distress and pain during pelvic examinations: Effect of sexual violence. Obstet Gynecol. 2008;112(6):1343-1350.
51. Weitlauf JC, Frayne SM, Finney JW, et al. Sexual violence, posttraumatic stress disorder, and the pelvic examination: How do beliefs about the safety, necessity, and utility of the examination influence patient experiences?. JWomens Health (Larchmt). 2010;19(7):1271-1280.
52. Henderson JT,Weisman CS, Grason H. Are two doctors better than one? women's physician use and appropriate care. Womens Health Issues. 2002; 12(3):138-149.
53. Henderson JT,Weisman CS. Women's patterns of provider use across the lifespan and satisfaction with primary care coordination and comprehensiveness. Med Care. 2005;43(8):826-833.
54. Stormo AR, SaraiyaM, Hing E, Henderson JT, Sawaya GF. Women's clinical preventive services in the United States: who is doing what?. JAMA Intern Med. 2014;174(9):1512-1514.
55. Clancy CM, Massion CT. American women's health care: A patchwork quilt with gaps. JAMA. 1992;268(14):1918-1920.
56. Institute of Medicine. Clinical Preventive Services forWomen: Closing the Gaps.Washington, DC: Institute of Medicine; 2011.
57. Conry JA, Brown H. Well-Woman Task Force: Components of thewell-woman visit. Obstet Gynecol. 2015;126(4):697-701.